Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Tempus AI, Inc. (NASDAQ:TEM) have received a consensus recommendation of “Moderate Buy” from the ten research firms that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $45.56.

Several analysts recently issued reports on TEM shares. Piper Sandler initiated coverage on Tempus AI in a research note on Monday, August 12th. They issued a “neutral” rating and a $40.00 target price on the stock. William Blair initiated coverage on Tempus AI in a research note on Tuesday, July 9th. They set an “outperform” rating on the stock. Morgan Stanley began coverage on Tempus AI in a research note on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 price target for the company. Stifel Nicolaus started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $45.00 price target on the stock. Finally, Bank of America began coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $41.00 price objective for the company.

Tempus AI Stock Down 12.3 %

Shares of TEM stock opened at $52.09 on Wednesday. Tempus AI has a fifty-two week low of $22.89 and a fifty-two week high of $77.00. The company has a 50 day moving average of $44.16.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing analysts’ consensus estimates of ($4.41) by ($2.36). The company had revenue of $165.97 million for the quarter, compared to the consensus estimate of $159.10 million. On average, equities analysts predict that Tempus AI will post -6.51 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of TEM. Sandia Investment Management LP bought a new position in shares of Tempus AI during the 2nd quarter valued at approximately $136,000. Northwestern University bought a new position in shares of Tempus AI in the second quarter worth approximately $491,000. Squarepoint Ops LLC purchased a new stake in shares of Tempus AI in the second quarter worth $633,000. WINTON GROUP Ltd bought a new stake in shares of Tempus AI during the 2nd quarter valued at $634,000. Finally, Scientech Research LLC purchased a new position in shares of Tempus AI during the 2nd quarter valued at $756,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.